Oncology - European Medical Journal

Continue

Oncology

Filter
30 Nov 2017

SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer

Prague, Czech Republic, 28 November, 2017 – SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient…
23 Nov 2017

Treatment Approval Broadened to Include Earlier Stage Prostate Cancer Patients

AN UNMET need in prostate cancer patients could be filled following the extension of European Commission (EC) marketing authorisation of the combination…
13 Nov 2017

Significant Mortality Benefits of Mechanical Valves

MECHANICAL valves have very good long-term mortality benefits and should be used more often, particularly in younger patients who require mitral-valve…
30 Oct 2017

Call for Greater Cancer Clinical Trial Eligibility

RECOMMENDATIONS for wider eligibility criteria for cancer clinical trials are being voiced by The American Society of Clinical Oncology (ASCO) and…
24 Oct 2017

Introducing EMJ Oncology 5.1

United Kingdom, October 24, 2017: Welcome to this year’s issue of EMJ Oncology, which is filled with the latest developments from the world of cancer…
9 Oct 2017

Advanced Stage III Melanoma: Brand New Adjuvant Therapy Discovered

A NOVEL combination of dabrafenib and trametinib has proven a successful adjuvant therapy for Stage III BRAF-mutant melanoma patients, doubling…
11 Sep 2017

Robust Performance of OncoBEAM™ RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients Highlighted at ESMO 2017

Hamburg, Germany, 08 September, 2017 – Sysmex Inostics, a subsidiary of Sysmex Corporation, a global leader in blood based circulating tumor DNA (ctDNA)…
30 Aug 2017

Philips supports global transformation of pathology with two new fully digitized labs in Austria

Amsterdam, 29 August, 2017 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the continued momentum of…
We’ve noticed you’re accessing
from North/South America.